KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Free Cash Flow (2016 - 2025)

LifeMD (LFMD) has disclosed Free Cash Flow for 14 consecutive years, with -$9.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 234.76% year-over-year to -$9.6 million, compared with a TTM value of $201636.0 through Dec 2025, down 98.74%, and an annual FY2025 reading of $201636.0, down 98.74% over the prior year.
  • Free Cash Flow was -$9.6 million for Q4 2025 at LifeMD, down from -$944394.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $10.5 million in Q2 2025 and bottomed at -$11.6 million in Q2 2021.
  • Average Free Cash Flow over 5 years is -$2.0 million, with a median of -$1.8 million recorded in 2023.
  • The sharpest move saw Free Cash Flow skyrocketed 637.26% in 2024, then crashed 2972.8% in 2025.
  • Year by year, Free Cash Flow stood at -$4.1 million in 2021, then crashed by 146.53% to -$10.1 million in 2022, then surged by 155.4% to $5.6 million in 2023, then grew by 27.69% to $7.2 million in 2024, then tumbled by 234.76% to -$9.6 million in 2025.
  • Business Quant data shows Free Cash Flow for LFMD at -$9.6 million in Q4 2025, -$944394.0 in Q3 2025, and $10.5 million in Q2 2025.